New study shows fatal effects of nicotine exposure during pregnancy may be curable
NEW YORK Researchers may have discovered a simple drug treatment to reverse the often otherwise terminal effects of nicotine exposure to an unborn child.
Based on data from a recent study on rates by researchers at McMaster University, nicotine exposure hinders a newborn’s ability to respond to low oxygen levels known as hypoxia.
Hypoxia can refer to episodes of apnea or moments of irregular breathing. When healthy babies are deprived of oxygen a hormone is released to trigger a deep breath. However, in infants subjected to nicotine during pregnancy this innate response is impaired and can result in sudden infant death syndrome.
The study, performed on rats, showed that the diabetic medication glibenclamide can increase the infant’s ability to react and respond to hypoxia, thus reversing the fatal effects of SIDS.
Data was published on June 3 in the Journal of Neuroscience.
Garden of Life teams up with WomenHeart
WEST PALM BEACH, Fla. Garden of Life on Tuesday announced it is teaming up with WomenHeart, the National Coalition for Women with Heart Disease, to improve the health and quality of life of women living with or at risk of heart disease.
“We are privileged to work with WomenHeart to help provide education, support and hope to millions of women at risk or suffering from heart disease,” stated Brian Ray, president.
As part of the partnership, Garden of Life will feature a WomenHeart logo on the packaging of its recently-launched Oceans 3 Healthy Hormones dietary supplement, a percentage of sales from will be donated to WomenHeart, the company stated.
Study suggests probiotics may affect metabolism
TORRANCE, Calif. Results of a new study published in the journal Molecular Systems Biology showed probiotics have a tangible effect on metabolism — suggesting that the digestive flora may provide weight loss benefits in addition to helping to maintain digestive health.
Researchers from Imperial College London and Nestle Research Center in Lausanne, Switzerland, fed mice two different strains of probiotics, Lactobacillus paracasei and Lactobacillus rhamnosus. Each strain showed a range of biochemical effects that were markedly different.
They also observed that one biological change was in how the treated mice metabolized bile acids. The primary function of bile acids is to emulsify fats in the upper gut. If probiotics influences the way bile acids are metabolized, they could change the amount of fat the body can absorb.